Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 21, 2020, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg.".
Press Release Oct 21 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Alembic Pharmaceuticals Limited on 6ix
Earlier from Alembic Pharmaceuticals
- Press Release Oct 16 2020
- Press Release Oct 13 2020
- Press Release Sep 07 2020
- Press Release Aug 27 2020
- Press Release Aug 25 2020
Later from Alembic Pharmaceuticals
- Press Release Oct 22 2020
- Press Release Oct 26 2020
- Press Release Nov 09 2020
- Press Release Nov 25 2020
- Press Release Dec 02 2020
Follow Alembic Pharmaceuticals into a list and get an email when it puts out news.
Follow Alembic Pharmaceuticals